Last reviewed · How we verify
NCT01399385
New Heart Imaging Techniques to Evaluate Possible Heart Disease
NA trial testing MR Imaging Techniques - 1 in Healthy in 4,000 participants. Currently enrolling.
6 November 2028
Quick facts
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | sequential |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 4,000 |
| Start date | 6 July 2011 |
| Primary completion | 6 November 2028 |
| Estimated completion | 5 November 2030 |
| Sites | 1 location across United States |
Drugs / interventions tested
- MR Imaging Techniques - 1
- MR Imaging Techniques - 2
- MR Imaging Techniques - 3
- MR Imaging Techniques - 4
Conditions studied
- Healthy — all drugs for Healthy →
- Obesity — all drugs for Obesity →
- Diabetes — all drugs for Diabetes →
- Healthy Volunteers — all drugs for Healthy Volunteers →
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Who can join
Adults 18 to 100, any sex, with Healthy or Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: \- Imaging tests, such as magnetic resonance imaging (MRI), can provide information about heart and blood vessels. The tests let doctors can see the amount of blood vessel narrowing and vessel wall thickness. This information may help diagnose and treat heart disease and other conditions that lead to heart attacks. Better MRI methods are needed to improve heart disease diagnosis, especially by avoiding the use of radiation. Researchers are testing new techniques to improve the quality of heart MRI, compared with more complex studies like catheterization or angiography. Objectives: \- To compare heart MRI techniques with other tests used to diagnose heart disease. Eligibility: \- People at least 18 years of age who either have or may have heart disease, or are healthy volunteers. Design: * Participants will be screened with a physical exam, medical history, and blood tests. * They will have an angiography to study the inside of blood vessels. This test is an x-ray study of the blood vessels. It will be done either separately or as part of a set of tests to diagnose possible heart disease. * Participants will have at least one and up to five MRI scans. The scans will involve different methods of studying the heart and blood vessels. Participants may also have a computed tomography scan to confirm the findings of an MRI scan. * No treatment will be provided as part of this protocol....
Publications & conference data
8 peer-reviewed publications reference this trial (live from Europe PMC):
-
Hypercortisolism is associated with increased coronary arterial atherosclerosis: analysis of noninvasive coronary angiography using multidetector computerized tomography.
Neary NM, Booker OJ, Abel BS, Matta JR, et al · · 2013 · cited 59× · PMID 23559084 · DOI 10.1210/jc.2012-3754 -
Automatic Coronary Wall and Atherosclerotic Plaque Segmentation from 3D Coronary CT Angiography.
Ghanem AM, Hamimi AH, Matta JR, Carass A, et al · · 2019 · cited 22× · PMID 30631101 · DOI 10.1038/s41598-018-37168-4 -
Proton MR Spectroscopy Measurements of White and Brown Adipose Tissue in Healthy Humans: Relaxation Parameters and Unsaturated Fatty Acids.
Ouwerkerk R, Hamimi A, Matta J, Abd-Elmoniem KZ, et al · · 2021 · cited 19× · PMID 33724063 · DOI 10.1148/radiol.2021202676 -
Coronary calcification in adults with Turner syndrome.
Schoepp M, Hannah-Shmouni F, Matta J, Ghanem AM, et al · · 2018 · cited 18× · PMID 29176683 · DOI 10.1038/gim.2017.149 -
Coronary atherosclerosis and dilation in hyper IgE syndrome patients: Depiction by magnetic resonance vessel wall imaging and pathological correlation.
Abd-Elmoniem KZ, Ramos N, Yazdani SK, Ghanem AM, et al · · 2017 · cited 17× · PMID 28167354 · DOI 10.1016/j.atherosclerosis.2017.01.022 -
Endothelial Dysfunction in Youth-Onset Type 2 Diabetes: A Clinical Translational Study.
Abd-Elmoniem KZ, Edwan JH, Dietsche KB, Villalobos-Perez A, et al · · 2024 · cited 12× · PMID 39069898 · DOI 10.1161/circresaha.124.324272 -
Sexual Dimorphism of Coronary Artery Disease in a Low- and Intermediate-Risk Asymptomatic Population: Association with Coronary Vessel Wall Thickness at MRI in Women.
Ghanem AM, Matta JR, Elgarf R, Hamimi A, et al · · 2019 · cited 7× · PMID 32076665 · DOI 10.1148/ryct.2019180007 -
Association of Coronary Wall Thickening and Diminished Diastolic Function in Asymptomatic, Low Cardiovascular Disease-Risk Persons Living with HIV.
Abd-Elmoniem KZ, Ishaq H, Purdy J, Matta J, et al · · 2024 · cited 3× · PMID 38573125 · DOI 10.1148/ryct.230102
Verify or expand the search:
- PubMed search for NCT01399385
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) trials
Trials by the same sponsor.
- NCT07313787 — Effects of Meal Macronutrients on Postprandial Lipids · Phase 2 · not yet recruiting
- NCT07388537 — Evaluation of the Clinical Spectrum of Diabetes and Obesity in Youth and Adults · not yet recruiting
- NCT05713799 — Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity · Phase 2 · not yet recruiting
- NCT05722210 — Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant · not yet recruiting
- NCT07191561 — Hepatic Lipid Metabolism-Alcohol Use Disorder · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01399385 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Last refreshed: 14 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01399385.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing